Atlas Trials

Investigation of the Safety and Efficacy of NTCELL® [Immunoprotected (Alginate-Encapsulated) Porcine Choroid Plexus Cells for Xenotransplantation] in Patients With Parkinson's Disease

Clinical trial NCT02683629 · COMPLETED

Trial details

NCT number
NCT02683629
Sponsor
Living Cell Technologies
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Parkinson's Disease
Start date
2016-02-01
Primary completion
2017-10-01
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.